The opportunity to present original research, case series, case reports, and review articles to the San Diego Dermatology Symposium attendees is an integral part of the conference’s continuing education program. Encore abstracts/posters are permitted. We will allow posters with data that has already been published within the last 6 months, assuming that appropriate copyright permissions are obtained from the journal. Posters will be on display at the meeting on poster boards and will be available on the SDDS website until August 31, 2024.
The top 3 posters will be selected for a 10-minute oral presentation during a 30-minute poster session on Friday, February 2, 2024 from 1:15 – 1:45 p.m.
There also will be a break with poster authors on Saturday, February 3, 2024 from 9:45 – 10:30 a.m. At least one author for each poster must be present and next to the poster during this break.
Poster submission is a 2-step process:
Abstract Submission Rules & Guidelines
Submission deadline: 11:59pm Pacific Time on January 19, 2024. After this date/time, the submissions site will close automatically and can no longer accept submissions. There will be no exceptions to this policy.
Abstract submission fee: The fee is $725 per abstract. The fee for residents, fellows and dermatologists who graduated in 2021-2023 is $100 per abstract. The fee for students is $50 for a digital poster only. Each abstract must be submitted separately as a PDF. There is no limit on the number of abstracts a company may submit. Payment is required upon submission of this form. The fee is non-refundable.
Format: Abstracts must be submitted as .pdf documents.
File name: must include supporting company name and lead author’s last name.
Margins: 1-inch top, bottom, left and right, single spaced; laser printer quality.
Font: font size must be 12-point Times Roman.
Length: 400 words maximum inclusive of title, author, author's highest degree and affiliations. Abstracts should be a maximum of one 8.5” x 11” page.
Content: Abstracts should reflect content of the poster and must include the poster title. Abstracts should contain the following: a) introduction that states the purpose of the study; b) brief description of the procedure/study; c) brief description of the results; and d) conclusion. Tables/illustrations may not be included in abstracts.
Brand Names: Generic or scientific names of drugs/devices should be used in place of brand names. If brand name is necessary to understand poster content, it should be used only once (after the first mention of the drug or device’s name). Pharmaceutical or other support of any study should be acknowledged at the end of the abstract and at the end of the poster.
Copyright: Copyright is shared. The Dermatology Research and Education Foundation owns copyright for its own use. Author(s) retain the rights for all other uses.
Note: If you wish to have your poster posted on the SDDS website only, the fee is $600/per abstract. Pricing is available if interested in additional features such as uploading to the SDDS website audio slides, audio files/commentaries, and author videos for presentations.
The top 3 posters will be selected for a 10-minute oral presentation during a 30-minute poster session on Friday, February 2, 2024 from 1:15 – 1:45 p.m.
There also will be a break with poster authors on Saturday, February 3, 2024 from 9:45 – 10:30 a.m. At least one author for each poster must be present and next to the poster during this break.
Poster submission is a 2-step process:
- All abstracts are to be submitted electronically via the San Diego Dermatology Symposium website by January 19, 2024. All submissions will be reviewed and accepted based on scientific value and educational need. Abstracts may be submitted by dermatologists, dermatology residents/fellows, and members of industry. Abstracts may be submitted by students for e-posters only. Please allow up to 1 week from date of submission for notification of approval or denial.
- If approved, poster submissions of approved abstracts are electronically due on January 26, 2024.
Abstract Submission Rules & Guidelines
Submission deadline: 11:59pm Pacific Time on January 19, 2024. After this date/time, the submissions site will close automatically and can no longer accept submissions. There will be no exceptions to this policy.
Abstract submission fee: The fee is $725 per abstract. The fee for residents, fellows and dermatologists who graduated in 2021-2023 is $100 per abstract. The fee for students is $50 for a digital poster only. Each abstract must be submitted separately as a PDF. There is no limit on the number of abstracts a company may submit. Payment is required upon submission of this form. The fee is non-refundable.
Format: Abstracts must be submitted as .pdf documents.
File name: must include supporting company name and lead author’s last name.
Margins: 1-inch top, bottom, left and right, single spaced; laser printer quality.
Font: font size must be 12-point Times Roman.
Length: 400 words maximum inclusive of title, author, author's highest degree and affiliations. Abstracts should be a maximum of one 8.5” x 11” page.
Content: Abstracts should reflect content of the poster and must include the poster title. Abstracts should contain the following: a) introduction that states the purpose of the study; b) brief description of the procedure/study; c) brief description of the results; and d) conclusion. Tables/illustrations may not be included in abstracts.
Brand Names: Generic or scientific names of drugs/devices should be used in place of brand names. If brand name is necessary to understand poster content, it should be used only once (after the first mention of the drug or device’s name). Pharmaceutical or other support of any study should be acknowledged at the end of the abstract and at the end of the poster.
Copyright: Copyright is shared. The Dermatology Research and Education Foundation owns copyright for its own use. Author(s) retain the rights for all other uses.
Note: If you wish to have your poster posted on the SDDS website only, the fee is $600/per abstract. Pricing is available if interested in additional features such as uploading to the SDDS website audio slides, audio files/commentaries, and author videos for presentations.
Poster Submission Guidelines (upon abstract approval)
Submission deadline: 11:59pm Pacific Time on January 19, 2024
Content: Poster content should be organized into background, objective, methods, results, and conclusion. Inclusion of graphs, tables and other visuals is strongly recommended to enhance engagement. Include all authors and affiliations. All authors must disclose financial relationships. One original author is required to register for the conference. If you have multiple posters each poster must have a unique author registered for the conference.
Poster Formatting Guidelines:
Commercialism: Any display at the SDDS in which cost is underwritten by a pharmaceutical company or other entity must avoid commercialism. Drugs, instrumentation, or devices must not use brand names. If such situations occur, the author/exhibitor is responsible for identifying and clearly stating on the poster that a portion or portions of the cost were provided by the commercial company named.
Submission deadline: 11:59pm Pacific Time on January 19, 2024
Content: Poster content should be organized into background, objective, methods, results, and conclusion. Inclusion of graphs, tables and other visuals is strongly recommended to enhance engagement. Include all authors and affiliations. All authors must disclose financial relationships. One original author is required to register for the conference. If you have multiple posters each poster must have a unique author registered for the conference.
Poster Formatting Guidelines:
- Poster authors are responsible for printing their posterboards on a foam core sign. Posters must be printed on foam core, 48 W x 36 H in size (landscape).
- Digital posters will be available on the website. Digital posters must be formatted to 1920 W x 1080 H in size, landscape orientation and in PDF format.
Commercialism: Any display at the SDDS in which cost is underwritten by a pharmaceutical company or other entity must avoid commercialism. Drugs, instrumentation, or devices must not use brand names. If such situations occur, the author/exhibitor is responsible for identifying and clearly stating on the poster that a portion or portions of the cost were provided by the commercial company named.
